Results 11 to 20 of about 696,003 (270)

Recommendations for Rotavirus Vaccine

Pediatrics & Neonatology, 2013
Rotavirus infection has been the leading cause of gastroenteritis among children in Taiwan. Studies have shown that 40% of hospitalization for acute gastroenteritis can be prevented through the use of vaccines, including a live, attenuated monovalent rotavirus vaccine and a pentavalent, human-bovine reassortant rotavirus vaccine.
Ping-Ing Lee, Po-Yen Chen, Yhu-Chering Huang, Chin-Yun Lee, Chun-Yi Lu, Mei-Hwei Chang, Yung-Zen Lin, Nan-Chang Chiu, Yen-Hsuan Ni, Chung-Ming Chen, Luan-Yin Chang, Ren-Bin Tang, Li-Min Huang, Yung-Feng Huang, Kao-Pin Hwang, Betau Hwang, Tzou-Yien Lin   +16 more
doaj   +5 more sources

Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality

Vaccines, 2022
Rotavirus claims thousands of lives of children globally every year with a disproportionately high burden in low- and lower-middle income countries where access to health care is limited.
Tintu Varghese, Gagandeep Kang, A Duncan Steele   +2 more
exaly   +2 more sources

Rotavirus Strain Distribution before and after Introducing Rotavirus Vaccine in India

Pathogens, 2021
In April 2016, an indigenous monovalent rotavirus vaccine (Rotavac) was introduced to the National Immunization Program in India. Hospital-based surveillance for acute gastroenteritis was conducted in five sentinel sites from 2012 to 2020 to monitor the ...
Shainey Alokit Khakha, Sidhartha Giri, Geeta Gathwala   +2 more
exaly   +2 more sources

Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008–16: findings from the Global Rotavirus Surveillance Network

The Lancet Global Health, 2019
Summary Background Rotavirus vaccine use in national immunisation programmes has led to declines in hospital admissions for rotavirus gastroenteritis among children; however, the global impact of rotavirus vaccine introduction has not been described ...
N. Aliabadi, S. Antoni, J. Mwenda, G. Weldegebriel, J. Biey, D. Cheikh, K. Fahmy, N. Teleb, Hossam Ashmony, H. Ahmed, D. Daniels, D. Videbaek, A. Wasley, Simarjit Singh, L. H. D. Oliveira, G. Rey-Benito, Jennifer Sanwogou, P. Wijesinghe, J. Liyanage, B. Nyambat, Varja Grabovac, James D. Heffelfinger, K. Fox, Fem Julia, Paladin, Tomoka Nakamura, M. Agócs, J. Murray, T. Cherian, Catherine Yen, U. Parashar, F. Serhan, J. Tate, Adam L. Cohen   +33 more
semanticscholar   +3 more sources

Evidence of rotavirus vaccine impact in sub-Saharan Africa: Systematic review and meta-analysis

PLoS ONE, 2020
Background Over 34 countries in Africa have introduced rotavirus vaccine to their national immunization programs: monovalent (Rotarix®, RV1) and pentavalent (RotaTeq®, RV5) after South Africa introduced it in 2009.
Opolot Godfrey, Weidong Zhang, Cecilia Amponsem-Boateng, Timothy Bonney Oppong, Qingling Zhao, Dankang Li   +5 more
semanticscholar   +2 more sources

Introducing rotavirus vaccine in the Universal Immunization Programme in India: From evidence to policy to implementation

Vaccine, 2019
Highlights • India became one of the first countries in Asia to introduce rotavirus vaccine.• Rotavirus vaccine is being expanded to the entire country in a phase wised manner.• The new vaccine introduction strengthened the programme rather than ...
Akash Malik, Pradeep Haldar, Arindam Ray   +2 more
exaly   +2 more sources

Global estimates of rotavirus vaccine efficacy and effectiveness: a rapid review and meta-regression analysis. [PDF]

EClinicalMedicine
Summary: Background: Rotavirus is the leading cause of diarrhoea worldwide, particularly affecting young children. While national rotavirus immunization programs have reduced rotavirus morbidity and mortality, vaccine performance varies considerably ...
Prunas O, Asare EO, Sajewski E, Li Y, Pithawala Z, Weinberger DM, Warren JL, Armah GE, Cunliffe NA, Iturriza-Gómara M, Lopman BA, Pitzer VE.   +11 more
europepmc   +2 more sources

Rotavirus Vaccine Coverage and Surveillance of Adverse Events Following Immunization in a Birth Cohort of Children (2017-2023) in Suzhou, China. [PDF]

Vaccines (Basel)
Objectives: To analyze the changes in the proportion of the rotavirus vaccine among children born in the 2017–2023 cohort and to assess the current status of rotavirus vaccination coverage in Suzhou, China.
Gao J, Zhu K, Luan L, Zheng B, Xu J, Zhu Y, Fan X, Wang H, Liu N.   +8 more
europepmc   +2 more sources

Rotavirus strain distribution in Ghana pre- and post- rotavirus vaccine introduction

Vaccine, 2018
Background: Ghana introduced the monovalent rotavirus vaccine (Rotarix) into its national paediatric vaccination programme in May2012. Vaccine introduction was initiated nationwide and achieved >85% coverage within a few months.
Belinda Lartey, Susan Damanka, Francis Ekow Dennis   +2 more
exaly   +2 more sources

Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in Malawi. [PDF]

Viruses
High titres of rotavirus-specific maternal antibodies may contribute to lower rotavirus vaccine efficacy in low- and middle-income countries (LMICs). RV3-BB vaccine (G3P[6]) is based on a neonatal rotavirus strain that replicates well in the newborn gut ...
Morgan B, Lyons EA, Handley A, Bogdanovic-Sakran N, Pavlic D, Witte D, Mandolo J, Turner A, Jere KC, Justice F, Ong DS, Bonnici R, Boniface K, Donato CM, Mpakiza A, Meyer A, Bar-Zeev N, Iturriza-Gomara M, Cunliffe NA, Danchin M, Bines JE.   +20 more
europepmc   +2 more sources